Product Information
EPOGEN 20,000 UNITS/ML VIAL is a brand product labeled by Amgen Inc., priced at $320.1466 per ML under NDC 55513047810. Its NADAC has been published 52 times since Mar 19, 2025.
Strength
20000 [iU]/mL
Manufacturer
Amgen Inc.NDC
55513047810
Classification
Brand
Dosage Form
SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
3/19/2025
Active Ingredients
EPOETINApproval Type
Biologic (BLA)
FDA Application
BLA103234On Market Since
3/3/1997
Pharmacological Classes
Price Statistics
The NADAC for EPOGEN 20,000 UNITS/ML VIAL has been published 52 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $320.1466 per ML |
|---|---|
| All-time high | $320.1466 (Mar 11, 2026) |
| All-time low | $320.1466 (Mar 19, 2025) |
| 52-week high | $320.1466 |
| 52-week low | $320.1466 |
| Median price | $320.1466 |
| Average price | $320.1466 |
| Largest weekly change | 0.0% (Mar 26, 2025) |
| Weeks tracked | 52 |
| Tracking since | Mar 19, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the epoetin alfa market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amgen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
epoetin alfa market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Erythropoiesis-stimulating Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPOGEN 20,000 UNITS/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for EPOGEN 20,000 UNITS/ML VIAL, manufactured by Amgen Inc., is $320.1466 per ML (NDC 55513047810), effective Mar 11, 2026.
How has the price of EPOGEN 20,000 UNITS/ML VIAL changed over time?
Over the history we have for it, the NADAC for EPOGEN 20,000 UNITS/ML VIAL has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for EPOGEN 20,000 UNITS/ML VIAL?
Since Mar 19, 2025, the NADAC for EPOGEN 20,000 UNITS/ML VIAL has ranged from a low of $320.1466 (Mar 19, 2025) to a high of $320.1466 (Mar 11, 2026), with a median of $320.1466 per ML.
Are there cheaper alternatives to EPOGEN 20,000 UNITS/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of EPOGEN 20,000 UNITS/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EPOGEN 20,000 UNITS/ML VIAL?
EPOGEN 20,000 UNITS/ML VIAL (NDC 55513047810) is labeled by Amgen Inc., and CMS classifies it as a brand product.